Financial Statements

Vertex Pharmaceuticals Incorporated (VRTX)


+9.05 (+3.19%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 859-1,853-2,989-5,120-
Net Income 2,3422,7121,1772,097263
Stock Dividends 0--4033-5,383
Dividend Paid -----
Retained Earnings 3,201859-1,853-2,989-5,120

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 959745812789-
Annual Depreciation 70147391181,049
Capital Expenditure -235-260-75-96-259
Net PPE 1,424959745812789

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -50501,0021,002
New Purchases -533-515-577-451-605
Intangible and Goodwill 50501,0021,0021,002

Vertex Pharmaceuticals Incorporated income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Vertex Pharmaceuticals Incorporated FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.